ZSCAN22
Zinc finger and SCAN domain-containing protein 22
Also known as: HKR2, ZNF50, ZSC22_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10073
- Gene
- ZSCAN22
- Ensembl
- ENSG00000182318
- Chromosome
- 19
- Canonical length
- 491 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Plasma membrane,Actin filaments,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
491 residues, UniProt reviewed canonical sequence.
>P10073|ZSCAN22
1 MAIPKHSLSP VPWEEDSFLQ VKVEEEEEAS LSQGGESSHD HIAHSEAARL RFRHFRYEEA
61 SGPHEALAHL RALCCQWLQP EAHSKEQILE LLVLEQFLGA LPPEIQAWVG AQSPKSGEEA
121 AVLVEDLTQV LDKRGWDPGA EPTEASCKQS DLGESEPSNV TETLMGGVSL GPAFVKACEP
181 EGSSERSGLS GEIWTKSVTQ QIHFKKTSGP YKDVPTDQRG RESGASRNSS SAWPNLTSQE
241 KPPSEDKFDL VDAYGTEPPY TYSGKRSSKC RECRKMFQSA SALEAHQKTH SRKTPYACSE
301 CGKAFSRSTH LAQHQVVHTG AKPHECKECG KAFSRVTHLT QHQRIHTGEK PYKCGECGKT
361 FSRSTHLTQH QRVHTGERPY ECDACGKAFS QSTHLTQHQR IHTGEKPYKC DACGRAFSDC
421 SALIRHLRIH SGEKPYQCKV CPKAFAQSSS LIEHQRIHTG EKPYKCSDCG KAFSRSSALM
481 VHLRIHITVL QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZSCAN22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 2.5 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 2.5 nTPM
- cerebellum: 2.4 nTPM
- liver: 2.2 nTPM
- skin: 2.2 nTPM
- esophagus: 1.7 nTPM
- cervix: 1.6 nTPM
Single-cell type
- retinal ganglion cells: 7.7 nCPM
- epicardial cells: 6.8 nCPM
- cardiomyocytes: 6.7 nCPM
- early primary spermatocytes: 5.6 nCPM
- melanocytes: 5.5 nCPM
- lacrimal acinar cells: 5.4 nCPM
Immune cell
- gdT-cell: 2 nTPM
- memory CD8 T-cell: 1.6 nTPM
- MAIT T-cell: 1.3 nTPM
- NK-cell: 1.2 nTPM
- memory CD4 T-cell: 1.1 nTPM
- myeloid DC: 1.1 nTPM
Brain region
- cerebellum: 9.1 nTPM
- white matter: 8.5 nTPM
- cerebral cortex: 6.7 nTPM
- medulla oblongata: 6.1 nTPM
- pons: 6.1 nTPM
- amygdala: 6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.22
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZSCAN22 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZSCAN22 as an antibody target. Whether an autoantibody or antibody against ZSCAN22 could matter depends on whether native ZSCAN22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZSCAN22 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZSCAN22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...